Lucía Santomé

Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy

Juan Ruiz‐Bañobre, María C. Areses-Manrique, Joaquín Mosquera et al. · Translational Lung Cancer Research · 2019 · 62 citations · Full text

Medicine, Immunology, Oncology +17

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

Juan Ruiz‐Bañobre, Aurea Molina-Díaz, O. Fernández-Calvo et al. · ESMO Open · 2021 · 47 citations · Full text

Medicine, Immunology, Oncology +16

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

Sergio Vázquez‐Estévez, J. Casal, Francisco Javier Afonso Afonso et al. · Cancer Management and Research · 2016 · 19 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study

Enriqueta Felip, Rafael Rosell, Manuel Dómine et al. · Annals of Oncology · 2003 · 13 citations · Full text

Medicine, Oncology, Pharmacology +13

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

J. Casal Rubio, José Luis Fírvida-Pérez, Martín Lázaro-Quintela et al. · Cancer Chemotherapy and Pharmacology · 2013 · 12 citations · Full text

Medicine, Oncology, Pharmacology +17